Long-Term Data On Medtronic AAA Graft Prompts FDA Public Health Notice
This article was originally published in The Gray Sheet
Executive Summary
FDA says that new long-term data shows that the aneurysm-related mortality in patients treated with Medtronic's AneuRx abdominal aortic aneurysm (AAA) graft is "substantially higher" than the mortality rate for open surgical repair